A systematic review of qualitative research on HIV and food insecurity in high-income countries.

AIDSMay 25, 2026 (epub)
Clinical ResearchInfectious DiseasesInternal Medicine (General)

Emily Jay Nicholls, P Bicarregui, Anna Brewster et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review synthesized qualitative research on food insecurity among people living with HIV in high-income countries, focusing on studies from the US and Canada. It identified three key themes related to structural inequalities, health impacts, and the labor involved in acquiring food. The review included 12 articles after screening 2772.

Key findings

  • Food insecurity leads to adverse health outcomes, including obesity and poor mental health.
  • Three key themes were identified: structural inequalities, health impacts, and food acquisition labor.
  • The review highlights the syndemic nature of food insecurity and HIV.

Why it matters

Understanding the interplay between food insecurity and HIV is crucial for developing effective interventions. Addressing these interconnected issues can improve health outcomes for affected individuals in high-income settings.

Source

PubMed · PMID 42186786

Published in AIDS. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.